The role and therapeutic potential of connexins, pannexins and their channels in Parkinson's disease
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 58, 111-118
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
This publication has 115 references indexed in Scilit:
- ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannelsJournal of Neurochemistry, 2011
- FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannelsProceedings of the National Academy of Sciences, 2010
- The Pannexin 1 Channel Activates the Inflammasome in Neurons and AstrocytesJournal of Biological Chemistry, 2009
- Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte–astrocyte gap junctionsEuropean Journal of Neuroscience, 2008
- Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseasesFree Radical Biology and Medicine, 2008
- Glial cells as intrinsic components of non-cell-autonomous neurodegenerative diseaseNature Neuroscience, 2007
- Identification of connexin36 in gap junctions between neurons in rodent locus coeruleusNeuroscience, 2007
- Connexin Hemichannels and Gap Junction Channels Are Differentially Influenced by Lipopolysaccharide and Basic Fibroblast Growth FactorMolecular Biology of the Cell, 2007
- Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptorThe EMBO Journal, 2006
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003